A follow-up analysis on whether Korean construction stocks can rerate. The core conclusion is not a broad housing-led sector rerating, but a selective reclassification of EPC names tied to nuclear, SMR, AI data center power, energy infrastructure and reconstruction.
A proprietary Korea Top 100 screen combining two-month Naver consensus target-price gaps, target revisions, foreign plus real-money flow, and 20/50-day trend position. KB Financial and Hana Financial are the only comfortable entries. Samsung Biologics is a watch item, while Hanwha Aerospace, Samyang Foods, and Alteogen need confirmation.
A follow-up framework on Korea's U.S. nuclear opportunity. Hyundai E&C has the more direct U.S. execution exposure through Fermi AP1000 and Holtec SMR-300. Woojin has the smaller but more asymmetric instrumentation option. The key gates are Hyundai's contract structure and Woojin's still-unverified AP1000 adoption.
A proprietary Thesis OS screen combining 1,137 Naver ETF constituent scans and local investor-flow data to identify Korean semiconductor second-line equipment, substrate, inspection and AI storage candidates that could outperform Samsung Electronics and SK Hynix over the next two months.
A review of the first half of June: U.S. jobs, CPI, PPI, Jensen Huang's Korea visit, the SpaceX IPO, foreign selling in Korean memory stocks, and the June 12 rebound. The conclusion is not easing confirmation, but a stress test for rates, oil, and crowded AI positioning.
A strategy note combining Korean semiconductor market-cap proxies and full ETF exposure data. The key is to separate absolute ETF ownership, market-cap-adjusted ETF sensitivity, and under-owned ETF gap candidates such as TCK, Daeduck Electronics, Korea Circuit and Doosan Tesna.
A sober read on what the US directive against Anthropic Fable 5 and Mythos 5 changes for Korea's sovereign AI thesis and Upstage, and what it does not yet change.
A framework for reading Korea's $350 billion U.S. strategic investment law through the nuclear value chain. The note separates nuclear beta in Doosan Enerbility, Hyundai E&C and KEPCO E&C from potential follow-on alpha in KEPCO KPS, Woori Technology, Woojin and power-equipment suppliers.
This is not a central-bank QE tape. It is a regulation-adjusted liquidity regime. We map U.S. dealer balance-sheet easing, Korea's WGBI / Value-up / capital-rule easing, and Japan's cash-to-market shift into one frame, and put Korean financials, U.S. market infrastructure and Japanese governance plays as the first-order winners.